Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring

Science

Volumn 343, Issue 6171, 2014, Pages 675-679

  Tyzio, Roman ^a,b   Nardou, Romain ^c   Ferrari, Diana C ^c   Tsintsadze, Timur ^a,b,c   Shahrokhi, Amene ^c,e   Eftekhari, Sanaz ^c,e   Khalilov, Ilgam ^a,b   Tsintsadze, Vera ^a,b   Brouchoud, Corinne ^a,b   Chazal, Genevieve ^a,b   Lemonnier, Eric ^d   Lozovaya, Natalia ^a,b   Burnashev, Nail ^a,b   Ben Ari, Yehezkel ^a,b,c  

^a Turing Center for Living Systems CENTURI Aix Marseille University   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Neurochlore Campus Scientific de Luminy   (France)

^d Laboratory of Neurosciences of Brest EA4685 University of Western Brittany   (France)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ARECAIDINE; BUMETANIDE; CHLORIDE; OXYTOCIN; VALPROIC ACID;

DATA SET; GAMMA RAY RADIATION; GENETIC ANALYSIS; HORMONE; INHIBITION; NUMERICAL MODEL; ORGANIC ACID; PATHOGENICITY; PHYSIOLOGY; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; AUTISM; BRAIN ELECTROPHYSIOLOGY; CHLORIDE BLOOD LEVEL; CONTROLLED STUDY; CYTOPLASM; DELIVERY; EXCITATORY POSTSYNAPTIC POTENTIAL; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; LABOR; MEDIATOR; MOTHER; MOUSE; NERVE CELL; NERVE CELL EXCITABILITY; NERVE CELL INHIBITION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGENY; RAT; RODENT; SIGNAL TRANSDUCTION; STRESS;

EID: 84893640636     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1247190     Document Type: Article

References (26)

1. R. L. H. Pobbe et al., Horm. Behav. 61, 436-444 (2012).
2. J. L. R. Rubenstein, M. M. Merzenich, Genes Brain Behav. 2, 255-267 (2003).
3. N. Gogolla et al., J. Neurodev. Disord. 1, 172-181 (2009).
4. G. J. Blatt, S. H. Fatemi, Anat. Rec. (Hoboken) 294, 1646-1652 (2011).
5. Y. Ben-Ari, J. L. Gaiarsa, R. Tyzio, R. Khazipov, Physiol. Rev. 87, 1215-1284 (2007).
6. C. Rivera et al., Nature 397, 251-255 (1999).
7. R. Tyzio et al., Science 314, 1788-1792 (2006).
8. M. Mazzuca et al., Front. Cell. Neurosci. 5, 3 (2011).
9. Materials and methods are available as supplementary materials on Science Online.
10. R. Nardou et al., Brain 134, 987-1002 (2011).
11. M. Puskarjov, F. Ahmad, K. Kaila, P. Blaesse, J. Neurosci. 32, 11356-11364 (2012).
12. H. Fiumelli, M. A. Woodin, Curr. Opin. Neurobiol. 17, 81-86 (2007).
13. R. Delorme et al., Nat. Med. 19, 685-694 (2013).
14. L. Cornew, T. P. L. Roberts, L. Blaskey, J. C. Edgar, J. Autism Dev. Disord. 42, 1884-1894 (2012).
15. H. Lagercrantz, P. Bistoletti, Pediatr. Res. 11, 889-893 (1977).
16. W. Inoue et al ., Nat. Neurosci. 16, 605-612 (2013).
17. J. S. Kim et al ., J. Neurosci. 31, 13312-13322 (2011).
18. P. Boulenguez et al., Nat. Med. 16, 302-307 (2010).
19. K. Lyall, D. L. Pauls, D. Spiegelman, A. Ascherio, S. L. Santangelo, Autism Res. 5, 21-30 (2012).
20. E. J. Glasson et al ., Arch. Gen. Psychiatry 61, 618-627 (2004).
21. F. Marrosu, G. Marrosu, M. G. Rachel, G. Biggio, Funct. Neurol. 2, 355-361 (1987).
22. S. F. Owen et al., Nature 500, 458-462 (2013).
23. T. R. Insel, Neuron 65, 768-779 (2010).
24. E. Lemonnier et al., Transl. Psychiatr. 2, e202 (2012).
25. E. Anagnostou et al., Mol. Autism 3, 16 (2012).
26. Y. Ben-Ari, Trends Neurosci. 31, 626-636 (2008).